Condition optimization of iron-air fuel cell to treat phosphate-containing wastewater regarding sustainable development.

Increasing use of phosphorus products and excessive exploitation of phosphorus resources become two major problems in perspective of phosphorus sustainable development. Phosphorus recovery is the shortcut to solve this dilemma. Combining electrochemistry, an iron-air fuel cell was adopted to recover phosphate and electricity from phosphate-containing wastewater in our previous studies. The present study focused on investigating the effects of catholyte/anolyte conductivity, external resistance, and anolyte pH on the performance of iron-air fuel cell, and obtaining the optimized conditions. Furthermore, the electrochemical methods of phosphate recovery were compared and assessed, and it is concluded that iron-air fuel cell has great potential for energy recovery. The phosphate removal efficiencies and vivianite yield roughly positively correlated with the catholyte conductivity and the anolyte pH, but negatively correlated with the external resistance and the anolyte conductivity. The electricity generation roughly positively correlated with the catholyte conductivity and anolyte conductivity, but showed limitations in the test range of anolyte pH and external resistance. To pursue high phosphate removal efficiencies and vivianite yield, the catholyte conductivity, external resistance, anolyte pH and anolyte conductivity were suggested to be 35 g-NaCl/L, 10 Ω, 8 and 0 g-NaCl/L. While if electricity generation was the primary goal, these parameters should be 35 g-NaCl/L, 220 Ω, 5 and 70 g-NaCl/L. The optimized conditions will help to improve the phosphate removal efficiency, vivianite yield and electricity generation, and to promote the development of iron-air fuel cell technology.

Clinical Characteristics of Patients with Drug-induced Liver Injury.

BACKGROUND: Drug is an important cause of liver injury and accounts for up to 40% of instances of fulminant hepatic failure. Drug-induced liver injury (DILI) is increasing while the diagnosis becomes more difficult. Though many drugs may cause DILI, Chinese herbal medicines have recently emerged as a major cause due to their extensive use in China. We aimed to provide drug safety information to patients and health carers by analyzing the clinical and pathological characteristics of the DILI and the associated drug types. METHODS: A retrospective analysis was conducted in 287 patients diagnosed with DILI enrolled in our hospital from January 2011 to December 2015. The categories of causative drugs, clinical and pathological characteristics were reviewed. RESULTS: Western medicines ranked as the top cause of DILI, accounting for 163 out of the 287 DILI patients (56.79%) in our study. Among the Western medicine, antituberculosis drugs were the highest cause (18.47%, 53 patients) of DILI.   Antibiotics (18 patients, 6.27%) and antithyroid (18 patients, 6.27%) drugs also ranked among the major causes of DILI. Chinese herbal medicines are another major cause of DILI, accounting for 36.59% of cases (105 patients). Most of the causative Chinese herbal medicines were those used to treat osteopathy, arthropathy, dermatosis, gastropathy, leukotrichia, alopecia, and gynecologic diseases. Hepatocellular hepatitis was prevalent in DILI, regardless of Chinese herbal medicine or Western medicine-induced DILI. CONCLUSIONS: Risks and the rational use of medicines should be made clear to reduce the occurrence of DILI. For patients with liver injury of unknown origin, liver tissue pathological examination is recommended for further diagnosis.

Muscarinic cholinergic regulation of L-type calcium channel in heart of embryonic mice at different developmental stages.

AIM: To investigate the muscarinic regulation of L-type calcium current (I(Ca-L)) during development. METHODS: The whole cell patch-clamp technique was used to record II(Ca-L) in mice embryonic cardiomyocytes at different stages (the early developmental stage, EDS; the intermediate developmental stage, IDS; and the late developmental stage, LDS). Carbachol (CCh) was used to stimulate M-receptor in the embryonic cardiomyocytes of mice. RESULTS: The expression of I(Ca-L) density did not change in different developmental stages (P>0.05). There was no difference in the sensitivity of I(Ca-L) to CCh during development (P>0.05). This inhibitory action of CCh was mediated by inhibition of cyclic AMP since 8-bromo-cAMP completely reversed the muscarinic inhibitory action. IBMX, a non-selective inhibitor of phosphodiesterase (PDE), reversed the inhibitory action of M-receptor on I(Ca-L) current by 71.2 %+/-9.2 % (n=8) and 11.3 %+/-2.5 % (n=9) in EDS and LDS respectively. However forskolin, an agonist of adenylyl cyclase (AC), reversed the action of CCh by 14.5 %+/-3.5 % (n=5) and 82.7 %+/-10.4 % (n=7) in EDS and LDS respectively. CONCLUSION: The inhibitory action of CCh on I(Ca-L) current was mediated in different pathways: in EDS, the inhibitory action of M-receptor on I(Ca-L) channel mainly depended on the stimulation of PDE. However, in LDS, the regulation by M-receptor on I(Ca-L) channel mainly depended on the inactivation of AC.